<DOC>
	<DOCNO>NCT01425489</DOCNO>
	<brief_summary>Development new MS-based biomarker early sensitive diagnosis Krabbe Disease plasma</brief_summary>
	<brief_title>Biomarker Krabbe Disease</brief_title>
	<detailed_description>Krabbe disease rare , hereditary degenerative disorder central peripheral nervous system . It characterize presence globoid cell ( cell one nucleus ) , breakdown nerve 's protective myelin coating , destruction brain cell . Krabbe disease one group genetic disorder call leukodystrophies . These disorder impair growth development myelin sheath , fatty cover act insulator around nerve fiber , cause se-vere deterioration mental motor skill . Myelin complex substance make least 10 different enzyme . Each leukodystrophies affect one ( one ) substance . Krabbe disease cause deficiency galactocere-brosidase , essential enzyme myelin metabolism . The disease often affect infant , onset age 6 month , occur adolescence adulthood . Symptoms include irritability , unexplained fever , limb stiffness , seizure , feed difficulty , vomit , slow mental motor development . Other symptom include muscle weakness , spasticity , deafness , blindness . Overall calculated European frequency 1 case per 100,000 population , high report incidence Sweden 1.9 case per 100,000 population . An unusually high incidence , 6 case per 1000 live birth , report Druze community Israel . New method , like mass-spectrometry give good chance characterize blood ( plasma ) affect patent specific metabolic alteration allow diagnose future disease earlier , high sensitivity specificity . Therefore goal study develop new biochemical marker plasma affected patient help benefit patient early diagnose thereby earlier treatment .</detailed_description>
	<mesh_term>Lysosomal Storage Diseases</mesh_term>
	<mesh_term>Leukodystrophy , Globoid Cell</mesh_term>
	<criteria>Informed consent obtain patient parent study related procedure . Patients gender one year old The patient diagnosis Krabbe Disease No Informed consent patient parent study related procedure . Patients young one year The patient diagnosis Krabbe Disease</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Leukodystrophy , Globoid Cell</keyword>
	<keyword>Hereditary Central Nervous System Demyelinating Diseases</keyword>
	<keyword>Brain Diseases , Metabolic , Inborn</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Sphingolipidoses</keyword>
	<keyword>Leukoencephalopathies</keyword>
	<keyword>Demyelinating Diseases</keyword>
	<keyword>Metabolism , Inborn Errors</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Lipidoses</keyword>
	<keyword>Lipid Metabolism , Inborn Errors</keyword>
	<keyword>Lysosomal Storage Diseases</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Lipid Metabolism DisordersLeukodystrophy , Globoid Cell</keyword>
</DOC>